These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14725787)

  • 41. In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane.
    Spitzer D; Unsinger J; Mao D; Wu X; Molina H; Atkinson JP
    J Immunol; 2005 Dec; 175(11):7763-70. PubMed ID: 16301687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the rabies virus from a human synthetic scFv phage display library and their fusion with the Fc region of human IgG1.
    Ray K; Embleton MJ; Jailkhani BL; Bhan MK; Kumar R
    Clin Exp Immunol; 2001 Jul; 125(1):94-101. PubMed ID: 11472431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
    Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
    Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decay-accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA).
    Ninomiya H; Abe T; Shichishima T; Terasawa T; Fujita T
    Br J Haematol; 1988 May; 69(1):81-7. PubMed ID: 2454648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
    Hillmen P; Hows JM; Luzzatto L
    Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
    Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
    Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes.
    Navenot JM; Muller JY; Blanchard D
    Transfusion; 1998 Apr; 38(4):337-42. PubMed ID: 9595015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor.
    Lederman MM; Purvis SF; Walter EI; Carey JT; Medof ME
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4205-9. PubMed ID: 2471198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A high m.w. form of decay-accelerating factor (DAF-2) exhibits size abnormalities in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Kinoshita T; Rosenfeld SI; Nussenzweig V
    J Immunol; 1987 May; 138(9):2994-8. PubMed ID: 2437202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring of scFv selected by phage display using detection of scFv-pIII fusion proteins in a microtiter scale assay.
    Mersmann M; Schmidt A; Tesar M; Schöneberg A; Welschof M; Kipriyanov S; Terness P; Little M; Pfizenmaier K; Moosmayer D
    J Immunol Methods; 1998 Nov; 220(1-2):51-8. PubMed ID: 9839925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
    Hayhurst A
    Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Humanization of an agonistic anti-death receptor 4 single chain variable fragment antibody and avidity-mediated enhancement of its cell death-inducing activity.
    Lee SH; Park DW; Sung ES; Park HR; Kim JK; Kim YS
    Mol Immunol; 2010 Jan; 47(4):816-24. PubMed ID: 19864027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Murine endoglin-specific single-chain Fv fragments for the analysis of vascular targeting strategies in mice.
    Müller D; Trunk G; Sichelstiel A; Zettlitz KA; Quintanilla M; Kontermann RE
    J Immunol Methods; 2008 Nov; 339(1):90-8. PubMed ID: 18790696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
    Qian YM; Haino M; Kelly K; Song WC
    Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains.
    Cochet O; Kenigsberg M; Delumeau I; Duchesne M; Schweighoffer F; Tocqué B; Teillaud JL
    Mol Immunol; 1998 Dec; 35(17):1097-110. PubMed ID: 10395199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms of evasion of Schistosoma mansoni schistosomula to the lethal activity of complement.
    Ramalho-Pinto FJ; Carvalho EM; Horta MF
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():111-6. PubMed ID: 1285336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.